This article examines post-market drug safety, highlighting surveillance mechanisms, regulatory responses, and case studies of approved drugs with hidden risks.

German pharma and chemical group Merck KGaA has added another pillar to its traceability and authentication platform, signing up Zebra Technologies as a partner for the recently launched M-Trust ...

Under the agreement, Hengrui Pharma has granted Merck exclusive rights to develop, manufacture, and commercialize HRS-5346 worldwide, excluding the Greater China region. Hengrui Pharma will ...

NEW YORK, March 27 (Reuters) - Merck & Co (MRK.N), opens new tab said ... Small-town Ireland nervous as Trump seeks to lure pharma investment to US 7:16 AM UTC Healthcare & Pharmaceuticalscategory ...

US President Donald Trump has again singled out Ireland's pharmaceutical industry as a target for tariffs. Trump was speaking as he announced 25% tariffs on cars and car parts imported into the US.

As a result, Merck underperformed the US market and its pharmaceuticals industry peers, highlighting external challenges that influenced its recent performance trajectory.

Merck (MRK), known as MSD outside of the United States and Canada, announced that the European Commission, or EC, has approved CAPVAXIVE, or Pneumococcal 21-valent Conjugate Vaccine, for active ...

Rahway: Merck, known as MSD outside of the United States and Canada, and Jiangsu Hengrui Pharmaceuticals Co., Ltd., a global pharmaceutical company focused on scientific and technological innovation, ...

(Image Credits: Pixabay) Merck on Tuesday announced that it has signed a deal with Jiangsu Hengrui Pharmaceuticals worth up to $2 billion. The deal will give the U.S. drugmaker access to an ...

(RTTNews) - Merck & Co., Inc. (MRK), a healthcare company, on Tuesday announced signing of an exclusive license agreement for HRS-5346 with Jiangsu Hengrui Pharmaceuticals Co., Ltd. HRS-5346 is an ...